PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB [DUR]) IN PATIENTS WITH GLIOBLASTOMA (GBM): RESULTS FOR COHORT B (DUR MONOTHERAPY), BEVACIZUMAB (BEV) NAIVE PATIENTS WITH RECURRENT GBM Conference Paper uri icon

authors

  • Reardon, David
  • Kaley, Thomas
  • Dietrich, Jorg
  • Lim, Michael
  • Dunn, Gavin
  • Gan, Hui
  • Cloughesy, Timothy
  • Clarke, Jennifer
  • Park, Andrew
  • Macri, Mary
  • Ryan, Aileen
  • Ricciardi, Toni
  • Reddy, Vijay
  • Venhaus, Ralph

publication date

  • November 1, 2016